[HTML][HTML] The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions

M Trøseid, GØ Andersen, K Broch, JR Hov - EBioMedicine, 2020 - thelancet.com
Host-microbiota interactions involving inflammatory and metabolic pathways have been
linked to the pathogenesis of multiple immune-mediated diseases and metabolic conditions …

The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease

RM Chakaroun, LM Olsson, F Bäckhed - Nature Reviews Cardiology, 2023 - nature.com
Despite milestones in preventive measures and treatment, cardiovascular disease (CVD)
remains associated with a high burden of morbidity and mortality. The protracted nature of …

The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases

J Zhen, Z Zhou, M He, HX Han, EH Lv… - Frontiers in …, 2023 - frontiersin.org
Morbidity and mortality of cardiovascular diseases (CVDs) are exceedingly high worldwide.
Researchers have found that the occurrence and development of CVDs are closely related …

Cardiovascular outcomes associated with use of clarithromycin: population based study

AYS Wong, A Root, IJ Douglas, CSL Chui, EW Chan… - bmj, 2016 - bmj.com
Study question What is the association between clarithromycin use and cardiovascular
outcomes? Methods In this population based study the authors compared cardiovascular …

Barriers to the conduct of randomised clinical trials within all disease areas

S Djurisic, A Rath, S Gaber, S Garattini, V Bertele… - Trials, 2017 - Springer
Background Randomised clinical trials are key to advancing medical knowledge and to
enhancing patient care, but major barriers to their conduct exist. The present paper presents …

Adverse events in people taking macrolide antibiotics versus placebo for any indication

MP Hansen, AM Scott, A McCullough… - Cochrane Database …, 2019 - cochranelibrary.com
Background Macrolide antibiotics (macrolides) are among the most commonly prescribed
antibiotics worldwide and are used for a wide range of infections. However, macrolides also …

[HTML][HTML] Idiopathic hypersomnia and other hypersomnia syndromes

LM Trotti, I Arnulf - Neurotherapeutics, 2021 - Elsevier
There are numerous disorders of known or presumed neurologic origin that result in
excessive daytime sleepiness, collectively known as the central disorders of …

Duration and life-stage of antibiotic use and risks of all-cause and cause-specific mortality: prospective cohort study

Y Heianza, W Ma, X Li, Y Cao, AT Chan… - Circulation …, 2020 - Am Heart Assoc
Rationale: The overuse of antibiotics has been an important clinical issue, and antibiotic
exposure is linked to alterations in gut microbiota, which has been related to risks of various …

The interaction of gut microbiota and heart failure with preserved ejection fraction: from mechanism to potential therapies

W Yu, Y Jiang, H Xu, Y Zhou - Biomedicines, 2023 - mdpi.com
Heart failure with preserved ejection fraction (HFpEF) is a disease for which there is no
definite and effective treatment, and the number of patients is more than 50% of heart failure …

The Impact of Antibiotics and Steroids on the Nasal Microbiome in Patients with Chronic Rhinosinusitis: A Systematic Review According to PICO Criteria

A Loperfido, C Cavaliere, E Begvarfaj… - Journal of Personalized …, 2023 - mdpi.com
Background: The nasal microbiome represents the main environmental factor of the
inflammatory process in chronic rhinosinusitis (CRS). Antibiotics and steroids constitute the …